Intestinal microecology and quality of life in irritable bowel syndrome patients.

Keywords

Irritable bowel syndrome, Microecology, Gastroenterology, Internal medicine, Medicine

References

• Endotoxin Actions on Myoelectric Activity, Transit, and Neuropeptides in the Gut (Role of Nitric Oxide)Per M. Hellström, Ahmad Al‐Saffar, Tryggve Ljung — 1997
• Long-term ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora.Toshifumi� Ohkusa, Yoshinori Ozaki, Chifumi Sato — 1995
• Gastroparesis and Small Bowel Dysmotility in Irritable Bowel SyndromePeter R. Evans, Young‐Tae Bak, Borys Shuter — 1997
• Modification of Colonic Fermentation by Bifidobacteria and pH In Vitro (Impact on Lactose Metabolism, Short-Chain Fatty Acid, and Lactate Production)Tianan Jiang, Dennis A. Savaiano — 1997
• Food-Related Gastrointestinal Symptoms in the Irritable Bowel SyndromeMagnus Simrén, Agneta Månsson, Anna Maria Langkilde — 2001
• Impact of irritable bowel syndrome on personal relationships and working practicesD. B. A. Silk — 2001
• The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats.Vincent B. Nieuwenhuijs, André Verheem, Henriëtte van Duijvenbode-Beumer — 1998
• Estimating the Importance of Infection in IBSRobert E. Spiller — 2003
• Normalization of Lactulose Breath Testing Correlates With Symptom Improvement in Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled StudyMark Pimentel, Evelyn J. Chow, Henry C. Lin — 2003
• Impact of Irritable Bowel Syndrome on Quality of Life and Resource Use in the United States and United KingdomBeth Hahn, Songkai Yan, Scott A. Strassels — 1999
• Antibiotics increase functional abdominal symptomsPR Maxwell, Elizabeth Rink, D. Kumar — 2002
• Nucleic acid-based fluorescent probes in microbial ecology: application of flow cytometry.Jonathan Porter, Roger Pickup — 2000
• Endotoxin temporarily impairs canine colonic absorption of water and sodium.Joseph J. Cullen, Stephen T. Spates, Kimberly S. Ephgrave — 1998
• Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials.R. Bruce Lydiard, Sherry A. Falsetti — 1999
• The impact of irritable bowel syndrome on health-related quality of life.Ian M. Gralnek, Ron D. Hays, Amy M. Kilbourne — 2000
• Health‐related quality of life and gastrointestinal diseaseH. Glise, Ingela Wiklund — 2002
• Abnormal colonic fermentation in irritable bowel syndrome.T. S. King, M. Elia, JO Hunter — 1998
• Functional bowel disorders and functional abdominal painWade Thompson, George F. Longstreth, Douglas A. Drossman — 1999
• History of recognition and measurement of colonization resistance of the digestive tract as an introduction to selective gastrointestinal decontamination.D. van der Waaij — 1992
• Socioeconomic impact of irritable bowel syndrome in Canada.Michel Boivin — 2001

Cited by

• Irritable bowel syndrome: the role of food in pathogenesis and management.Paula A. Hayes, Marianne Fraher, Eamonn M.M. Quigley — 2014
• Clinical studies on alleviating the symptoms of irritable bowel syndrome.Kajsa Kajander, Riitta Korpela — 2006
• Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndromeChristophe Chassard, Michel Dapoigny, Karen P. Scott — 2012
• Lactococcus lactis expressing food-grade β-galactosidase alleviates lactose intolerance symptoms in post-weaning Balb/c mice川田 敬一, 京都産業大学法学部研究科 — 2012
• Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.Clarence G. Goymour, M. Abon, G. Bergeret — 2014
• Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome.Cristina Almansa, Anurag K. Agrawal, Lesley A. Houghton — 2012
• Budget impact of tegaserod on a managed care organization formulary.Michael A Bloom, Victoria Barghout, Kristijan H. Kahler — 2005
• Immunomodulation of Antiretroviral Drug-Suppressed Chronic HIV-1 Infection in an Oral Probiotic Double-Blind Placebo-Controlled TrialOtto O. Yang, Theodoros Kelesidis, Robert Cordova — 2014
• Alterations in Composition and Diversity of the Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel SyndromeIan M. Carroll, Tamar Ringel‐Kulka, Jennica P. Siddle — 2012
• Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus InfectionHaifeng Lu, Zhongwen Wu, Wei Xu — 2011
• Aspects épidémiologiques et sémiologiques des troubles fonctionnels intestinaux dans les centres de santé de référence de BamakoM. Diarra, A. Konaté, A Souckho-Kaya — 2011
• Visceral hypersensitivity in Irritable Bowel Syndrome:pathophysiological mechanismsAngèle P. M. Kerckhoffs — 2009
• PATHOPHYSIOLOGICAL FACTORS OF IRRITABLE BOWEL SYNDROME, AND THE EFFECTS OF PROBIOTIC SUPPLEMENTATIONKajsa Kajander — 2008
• Mesalazine (5‐aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐predominant irritable bowel syndromeChristopher N. Andrews, Tanya A. M. Griffiths, Jaime Kaufman — 2011
• Distinct microbial populations exist in the mucosa‐associated microbiota of sub‐groups of irritable bowel syndromeG. C. Parkes, Neil B. Rayment, B N Hudspith — 2012
• Recent advances in the diagnosis of irritable bowel syndromeMagdy El‐Salhy — 2015
• Association of enteroaggregative Escherichia coli with irritable bowel syndrome.B M Sobieszczanska, Jacek Osek, Dorota Waśko−Czopnik — 2007
• Essential Oil Composition and Antimicrobial Activity of Angelica archangelica L. (Apiaceae) RootsDaniele Fraternale, Guido Flamini, Donata Ricci — 2014
• Laminaria japonica Combined with Probiotics Improves Intestinal Microbiota: A Randomized Clinical TrialSeok‐Jae Ko, Jinsung Kim, Gajin Han — 2014
• Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndromeKajsa Kajander, Lotta Krogius-Kurikka, Teemu Rinttilä — 2007

Related papers

• Analysis of the status of intestinal microecology and irritable bowel syndromeSI Jian-mi — 2007
• Effect of bifidbacterium SCS on microflora of Mice with DysbacteriosisMiao Ying-qiu — 2002
• Research on development of Bifidobacterium adolescentis-containing solidified yoghurt and selective medium for strainsHan Liu, Guan Hong, Wenqin Yang — 2011
• Features of the composition of the intestinal microbiota in patients with colorectal cancerС. В. Волков, С. Л. Лобанов, А. Yu. Dobrodeev — 2022
• THE MICROECOLOGICAL RESEARCH AND THE PREVENTION AND THERAPY OF ULCERATIVE COLITISDe Zhang — 2002
• Intestinal flora of patients untreated first-episode schizophrenia and its relationship with levels of IL-6, IL-10 and TNF-α in serumYongqi Shi, Huaili Deng, Binhong Wang — 2020
• Analysis of Bacteroides and Bifidobacterium diversity in fecal samples from patients with type IIdiabetes by using PCR-denaturing gradient gel electrophoresis fingerprintJuan Wang — 2010
• Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder.Emiko Aizawa, Hirokazu Tsuji, Takashi Asahara — 2016
• Age-related changes in the gut microbiota and the core gut microbiome of healthy Thai humansOrawan La-ongkham, Massalin Nakphaichit, Jiro Nakayama — 2020
• The protective effect of Lactobacillus and Bifidobacterium as the gut microbiota members against chronic urticariaAkram Rezazadeh, Shahram Shahabi, Morteza Bagheri — 2018